DK630589D0 - 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION - Google Patents
2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITIONInfo
- Publication number
- DK630589D0 DK630589D0 DK630589A DK630589A DK630589D0 DK 630589 D0 DK630589 D0 DK 630589D0 DK 630589 A DK630589 A DK 630589A DK 630589 A DK630589 A DK 630589A DK 630589 D0 DK630589 D0 DK 630589D0
- Authority
- DK
- Denmark
- Prior art keywords
- dideoxypurinnucleosid
- purine nucleoside
- inhibitor composition
- nucleoside phosphorylase
- phosphorylase inhibitor
- Prior art date
Links
- 229940123827 Purine nucleoside phosphorylase inhibitor Drugs 0.000 title 1
- 239000000784 purine nucleoside phosphorylase inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28415388A | 1988-12-14 | 1988-12-14 | |
| US31535489A | 1989-02-24 | 1989-02-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK630589D0 true DK630589D0 (en) | 1989-12-13 |
| DK630589A DK630589A (en) | 1990-06-15 |
Family
ID=26962435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK630589A DK630589A (en) | 1988-12-14 | 1989-12-13 | 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0374096B1 (en) |
| JP (1) | JPH02204414A (en) |
| KR (1) | KR900009083A (en) |
| AU (1) | AU628113B2 (en) |
| CA (1) | CA2005205A1 (en) |
| DE (1) | DE58902899D1 (en) |
| DK (1) | DK630589A (en) |
| IE (1) | IE893991L (en) |
| IL (1) | IL92587A (en) |
| NZ (1) | NZ231718A (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ229453A (en) * | 1988-06-10 | 1991-08-27 | Univ Minnesota & Southern Rese | A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents |
| KR100208315B1 (en) * | 1989-02-27 | 1999-07-15 | 에이. 몽고메리 존 | 9-substituted-8-unsubstituted-9-deazaguanines |
| JP2619710B2 (en) * | 1989-02-27 | 1997-06-11 | 日本製紙 株式会社 | Method for producing 2 ', 3'-dideoxypurine nucleosides |
| EP0465297B1 (en) * | 1990-07-04 | 1996-01-31 | Merrell Dow Pharmaceuticals Inc. | 9-Purinyl phosphonic acid derivatives |
| EP0513917B2 (en) * | 1991-05-16 | 2001-03-07 | Glaxo Group Limited | Antiviral combinations containing nucleoside analogs |
| US5494912A (en) * | 1991-06-26 | 1996-02-27 | Merrell Pharmaceuticals Inc. | 9-purinyl phosphonic acid derivitives for treating gout |
| CZ27399A3 (en) * | 1999-01-26 | 2000-08-16 | Ústav Experimentální Botaniky Av Čr | Substituted nitrogen heterocyclic derivatives process of their preparation, the derivatives employed as medicaments, pharmaceutical composition and a compound pharmaceutical preparation in which these derivatives are comprised as well as use of these derivatives for preparing medicaments |
| JP4570566B2 (en) * | 2003-08-26 | 2010-10-27 | 帝人ファーマ株式会社 | Pyrrolopyrimidinone derivatives |
| US7557113B2 (en) | 2003-08-26 | 2009-07-07 | Teijin Pharma Limited | Substituted pyrrolo[3,2-d]pyrimidine derivatives |
| DE102006017600A1 (en) * | 2006-02-09 | 2007-08-16 | Friedel, Ruthard, Dr. | Nucleoside analogues as gene expression regulators in viruses |
| US9616129B2 (en) * | 2013-06-22 | 2017-04-11 | Nitor Therapeutics | Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency |
| WO2018045045A1 (en) | 2016-08-30 | 2018-03-08 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods for treatment using small molecule potassium-sparing diuretics and natriuretics |
| GB201820098D0 (en) * | 2018-12-10 | 2019-01-23 | Cambridge Entpr Ltd | Methods of cancer treatment |
| GB201820095D0 (en) | 2018-12-10 | 2019-01-23 | Cambridge Entpr Ltd | Famin assay methods |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60126220A (en) * | 1983-12-09 | 1985-07-05 | Otsuka Pharmaceut Factory Inc | Nucleic acid component composition |
| WO1987001284A1 (en) * | 1985-08-26 | 1987-03-12 | United States Of America, Represented By The Unite | Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine |
-
1989
- 1989-12-05 DE DE8989810920T patent/DE58902899D1/en not_active Expired - Fee Related
- 1989-12-05 EP EP89810920A patent/EP0374096B1/en not_active Expired - Lifetime
- 1989-12-07 IL IL9258789A patent/IL92587A/en unknown
- 1989-12-08 AU AU46074/89A patent/AU628113B2/en not_active Ceased
- 1989-12-12 KR KR1019890018345A patent/KR900009083A/en not_active Withdrawn
- 1989-12-12 CA CA002005205A patent/CA2005205A1/en not_active Abandoned
- 1989-12-12 NZ NZ231718A patent/NZ231718A/en unknown
- 1989-12-13 DK DK630589A patent/DK630589A/en not_active Application Discontinuation
- 1989-12-13 IE IE893991A patent/IE893991L/en unknown
- 1989-12-13 JP JP1321624A patent/JPH02204414A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IE893991L (en) | 1990-06-14 |
| EP0374096A1 (en) | 1990-06-20 |
| JPH02204414A (en) | 1990-08-14 |
| DK630589A (en) | 1990-06-15 |
| KR900009083A (en) | 1990-07-02 |
| NZ231718A (en) | 1992-02-25 |
| AU628113B2 (en) | 1992-09-10 |
| EP0374096B1 (en) | 1992-12-02 |
| DE58902899D1 (en) | 1993-01-14 |
| AU4607489A (en) | 1990-06-21 |
| CA2005205A1 (en) | 1990-06-14 |
| IL92587A0 (en) | 1990-08-31 |
| IL92587A (en) | 1994-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT526253E (en) | ANALOGS OF NUCLEOSIDE 1,3-OXATIOLANE | |
| LV5781B4 (en) | Healing Nucleoside | |
| FI902386A7 (en) | Nucleoside analogues | |
| DK23489D0 (en) | nucleoside | |
| KR900007991A (en) | Primer composition | |
| DK375989A (en) | purine derivatives | |
| DK630589D0 (en) | 2 ', 3'-DIDEOXYPURINNUCLEOSID / purine nucleoside phosphorylase inhibitor COMPOSITION | |
| DK564088A (en) | nucleoside | |
| NO921679L (en) | PURIN NUCLEOSIDE PHOSPHORYLASE INHIBITORS | |
| NZ235534A (en) | 3'-azido-2',3'-dideoxy purine derivatives | |
| FI922014A7 (en) | Nucleoside derivatives | |
| EP0365849A3 (en) | Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives | |
| DE68914750D1 (en) | Therapeutic nucleosides. | |
| DK626989A (en) | adenosine | |
| DK95791A (en) | nucleoside analogues | |
| NO891835L (en) | PRODRUG FORMS OF 2 ', 3'-DIDEHYDRO-2', 3'-DIDEOXY NUCLEOSIDES. | |
| DK339189A (en) | purine derivatives | |
| DE69002365D1 (en) | ANTIVIRAL COMPOSITION. | |
| ZA899510B (en) | 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition | |
| ATE104675T1 (en) | THERAPEUTIC NUCLEOSIDES. | |
| NO921776D0 (en) | Nucleoside derivative | |
| IE891764L (en) | Nucleoside compositions | |
| GB8925039D0 (en) | Nucleoside derivatives | |
| GB8925037D0 (en) | Nucleoside derivatives | |
| FI940103L (en) | Preparation of 2',3'-deoxy-2',3'-didehydronucleosides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHB | Application shelved due to non-payment |